Description

(6,7-Dimethoxy-3-Methyl-4-Oxo-3,4-Dihydro-Quinazolin-2-Ylsulfanyl)-Acetic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its quinazolinone core structure. This compound is critical for B2B buyers requiring a reliable and consistent supply of key building blocks for complex active pharmaceutical ingredient (API) synthesis. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development and production of novel therapeutic agents.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the synthesis of complex drug molecules, particularly those targeting specific enzymatic pathways.
• API Development: Used in research and development for constructing the core scaffold of potential new Active Pharmaceutical Ingredients (APIs).
• Medicinal Chemistry Research: Employed as a building block for creating compound libraries in structure-activity relationship (SAR) studies.
• Biochemical Reagent: May be utilized in biochemical assays as a reference standard or inhibitor due to its specific heterocyclic structure.
• Organic Synthesis: Acts as a versatile intermediate for further chemical modifications, enabling the creation of novel chemical entities.

Basic Information

Product Name	(6,7-Dimethoxy-3-Methyl-4-Oxo-3,4-Dihydro-Quinazolin-2-Ylsulfanyl)-Acetic Acid
CAS No.	886500-86-3
Molecular Formula	C₁₃H₁₄N₂O₅S
Molecular Weight	310.33 g/mol
Synonyms	2-[(6,7-Dimethoxy-3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)thio]acetic acid; Quinazolin-2-ylthioacetic acid derivative; 886500-86-3; (6,7-Dimethoxy-3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)sulfanylacetic acid; 2-((6,7-Dimethoxy-3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)thio)acetic acid; 3-Methyl-6,7-dimethoxy-2-mercapto-4(3H)-quinazolinone acetic acid derivative
EINECS	Contact for details

Quality Control

Our (6,7-Dimethoxy-3-Methyl-4-Oxo-3,4-Dihydro-Quinazolin-2-Ylsulfanyl)-Acetic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets exacting standards for pharmaceutical R&D and intermediate use. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and physical characteristics is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider conditions under an inert atmosphere to ensure optimal stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.